Your session is about to expire
← Back to Search
Pelareorep for Multiple Myeloma
Study Summary
This trial is studying the side effects and best dose of a modified virus given with drugs that are already used to treat relapsed multiple myeloma.
- Multiple Myeloma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 108 Patients • NCT01199263Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Could you elucidate other research initiatives that have incorporated Pelareorep?
"Pelareorep was initially examined in 2002 by Manitoba Blood & Marrow Transplant Program CancerCare Manitoba. At present, 1387 studies have been concluded and 1275 are still ongoing - a hefty portion of these trials being conducted from Salt Lake City."
How many participants have enrolled in the experiment?
"This research is no longer accepting patients. It was first shared on October 24th 2018 and had its latest update on May 27th 2022. If you are searching for other studies, there are 807 trials targeting neoplasms or plasma cells that still require participants, along with 1275 calling for people to take part in Pelareorep testing."
What are the known possible risks associated with Pelareorep?
"The scarcity of evidence supporting the safety and efficacy of Pelareorep has caused our team at Power to assign it a score of 1 on a scale from 1 to 3."
Is this experiment accepting new participants?
"In keeping with the information available on clinicaltrials.gov, it is apparent that this particular trial has ceased enrollment. It was originally posted in October 2018 and last updated May 27th 2022; however, there are currently 2,082 other trials actively recruiting participants."
In what contexts is Pelareorep typically employed?
"Pelareorep is an effective remedy for ophthalmia, sympathetic eye diseases, branch retinal vein occlusions and macular edema."
Share this study with friends
Copy Link
Messenger